Skip to Main Content

Author Details

Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
1997
102
36
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37934854Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma.Neuro Oncol2024
36639156Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.J Immunother Cancer2023
37486991EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression.Neuro Oncol2023
37124531A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease.Front Oncol2023
37114557Targeting B7â¿¿H3 through EZH2 inhibition in MYCâ¿¿positive Group 3 medulloblastoma.Oncol Rep2023
36747867Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy.bioRxiv2023
36915612The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth.Neurooncol Adv2023
34077540Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.Neuro Oncol2022
35406445SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma.Cancers (Basel)2022
35344040Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth.Clin Cancer Res2022
35814855Radiation Therapy for Young Children Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant for Primary Brain Tumors.Adv Radiat Oncol2022
35618754Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35179215Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors.Int J Oncol2022
35143643Single-cell transcriptional analysis of human endothelial colony-forming cells from patients with low VWF levels.Blood2022
34477871A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy.Neuro Oncol2022
34021242Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile.Commun Biol2021
33494392A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma.Cancers (Basel)2021
33910002Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma.Cell Rep2021
33601323Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.Eur J Cancer2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33844835The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas.Neuro Oncol2021
33749791NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.J Neuropathol Exp Neurol2021
34409497Subgroup and subtype-specific outcomes in adult medulloblastoma.Acta Neuropathol2021
34545084Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma.Nat Commun2021
33984150Converging evidence for inhibition of transcriptional control in high-grade gliomas.Neuro Oncol2021
31594826Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma.Mol Cancer Ther2020
31969682Correction: BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.Oncogene2020
31844250BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.Oncogene2020
31755223Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort.Cancer Med2020
33086074Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG.Cell Rep2020
33063010Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.Neurooncol Adv2020
32743560Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.Cell Rep Med2020
32783945Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology.Cell Rep2020
32642704Proteasome inhibition as a therapeutic approach in atypical teratoid/rhabdoid tumors.Neurooncol Adv2020
32642682Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine.Neurooncol Adv2020
32180106Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.J Neurooncol2020
32145124MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).Brain Pathol2020
32268092Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma.Cell Rep2020
32567728The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.Mol Carcinog2020
32195191Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia.Front Oncol2020
32129445Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.Neuro Oncol2020
31595628Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.Pediatr Blood Cancer2020
30626740Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven medulloblastoma.JCI Insight2019
31863004scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
30230537Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.Int J Cancer2019
31382461Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis.J Clin Med2019
31515514Effect of early-stage autophagy inhibition in BRAF<sup>V600E</sup> autophagy-dependent brain tumor cells.Cell Death Dis2019
  • 1 - 50 of 102

Recommended Authors

Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 55
Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 52
Juan C Vasquez
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 11
Jessica M Rusert
University of California San Diego
Career Start Year 2013
Number of shared co-authors 26
Laura Sieber
Preclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2012
Number of shared co-authors 49
Giles W Robinson
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 66
Payal Jain
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 14
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Career Start Year 2009
Number of shared co-authors 79
Patricia Baxter
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 31
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2008
Number of shared co-authors 80
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 20
Eugene I Hwang
Children's National Hospital. Electronic address: .
Career Start Year 2004
Number of shared co-authors 62
Amy Smith
Arnold Palmer Hospital for Children
Career Start Year 2003
Number of shared co-authors 38
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 18
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 7
Nicholas G Gottardo
Perth Children's Hospital
Career Start Year 2002
Number of shared co-authors 45
Sheila K Singh
McMaster University
Career Start Year 2001
Number of shared co-authors 45
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 47
Ranjit S Bindra
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Career Start Year 1997
Number of shared co-authors 39
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 15
Tamar Uziel
AbbVie Inc.
Career Start Year 1995
Number of shared co-authors 8
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 24
Xiao-Nan Li
Northwestern University
Career Start Year 1992
Number of shared co-authors 74
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 71
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 25
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 25
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 5
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 39

Collaborators

Nicholas K Foreman
Co-authored papers 54
Sujatha Venkataraman
Co-authored papers 48
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 22
William A Weiss
University of California san francisco
Co-authored papers 13
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 13
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers 12
Joshua B Rubin
Washington University in St. Louis
Co-authored papers 12
Etienne Danis
University of Colorado Anschutz Medical Campus
Co-authored papers 12
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 11
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers 11
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers 11
Wies??awa Grajkowska
Children's Memorial Health Institute
Co-authored papers 11
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 11
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 11
Pim J French
Erasmus MC Cancer Institute
Co-authored papers 11
Toshihiro Kumabe
Kitasato University School of Medicine
Co-authored papers 11
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 11
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers 10
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 10
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 10
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Co-authored papers 9
Boleslaw Lach
McMaster University
Co-authored papers 9
Eric Bouffet
The Hospital for Sick Children
Co-authored papers 9
Anca Sorana Morrissy
Cumming School of Medicine, University of Calgary
Co-authored papers 9
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 9
Betty Luu
University of Wollongong
Co-authored papers 9
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 8
Uri Tabori
Co-authored papers 8
Anne Jouvet
Groupement Hospitalier EST, Universite de Lyon
Co-authored papers 8
Release 1.2